Our Research Publications
Updated November 2023
Pagination
- Previous page
- Page 10
- Next page
Title Sort ascending | Authors | Year | Journal | Link to Article | Intended Audience | Purpose |
---|---|---|---|---|---|---|
SARS-CoV-2 spike-dependent platelet activation in COVID-19 vaccine-induced thrombocytopenia | Appelbaum J, Arnold DM, Kelton JG, Gernsheimer T, Jevtic SD, Ivetic N, Smith JW, Nazy I | 2022 | Blood Adv | View SARS-CoV-2 spike-dependent platelet activation in COVID-19 vaccine-induced thrombocytopenia | Researchers | Basic research |
SARS-CoV-2 seroprevalence among Vancouver public school staff in British Columbia, Canada: a cross-sectional study | Goldfarb DM, Mâsse LC, Watts AW, Hutchison SM, Muttucomaroe L, Bosman ES, Barakauskas VE, Choi A, Dhillon N, Irvine MA, Reicherz F, O’Reilly C, Sediqi S, Xu RY, Razzaghian HR, Sadarangani M, Coombs D, O’Brien SF, Lavoie PM | 2022 | BMJ Open | View SARS-CoV-2 seroprevalence among Vancouver public school staff in British Columbia, Canada: a cross-sectional study | Researchers | Clinical research |
SARS-CoV-2 seroprevalence among Vancouver public school staff in British Columbia, Canada | Goldfarb DM, Mâsse LC, Watts AW, Hutchison SM, Muttucomaroe L, Bosman ES, Barakauskas VE, Choi A, Irvine MA, Reicherz F, Coombs D, O’Reilly C, Sediqi S, Razzaghian HR, Sadarangani M, O’Brien SF, Lavoie PM | 2021 | medRxiv | View SARS-CoV-2 seroprevalence among Vancouver public school staff in British Columbia, Canada | Researchers | Clinical research |
SARS-CoV-2 Seroprevalence among Canadian Blood Donors: The Advance of Omicron | O’Brien SF, Caffrey N, Yi Q-L, Pambrun C, Drews SJ | 2022 | Viruses | View SARS-CoV-2 Seroprevalence among Canadian Blood Donors: The Advance of Omicron | Researchers | Clinical research |
SARS-CoV-2 seroprevalence among blood donors after the first COVID-19 wave in Canada | Saeed S, Drews SJ, Pambrun C, Yi Q-L, Osmond L, O'Brien SF | 2021 | Transfusion | View SARS-CoV-2 seroprevalence among blood donors after the first COVID-19 wave in Canada | Researchers | Clinical research |
SARS in Canada: Lessons learned for the blood operator | Devine DV | 2020 | Transfus Med | View SARS in Canada: Lessons learned for the blood operator | Blood operators | Other |
Sample collection and sample handling errors submitted to the transfusion error surveillance system, 2006 to 2015 | Strauss R, Downie H, Wilson A, Mounchili A, Berry B, Cserti-Gazdewich C, Callum J | 2018 | Transfusion | View Sample collection and sample handling errors submitted to the transfusion error surveillance system, 2006 to 2015 | Health care providers | Clinical research |
Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials | Lalu MM, McIntyre L, Pugliese C, Fergusson D, Winston BW, Marshall JC, Granton J, Stewart DJ, Canadian Critical Care Trials Group | 2012 | PLoS One | View Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials | Researchers | Clinical research |
Safety of blood donation by individuals over age 70 and their contribution to the blood supply in five developed countries: a BEST Collaborative group study | Goldman M, Germain M, Gregoire Y, Vassallo RR, Kamel H, Bravo M, Irving DO, Di Angelantonio E, Steele WR, O'Brien SF, for the Biomedical Excellence for Safer Transfusion Collaborative (BEST) Investigators | 2019 | Transfusion | View Safety of blood donation by individuals over age 70 and their contribution to the blood supply in five developed countries: a BEST Collaborative group study | Blood operators | New or improved product or process |
Safety and efficacy of self-administered romiplostim in patients with immune thrombocytopenia: Results of an integrated database of five clinical trials | Kuter DJ, Arnold DM, Rodeghiero F, Janssens A, Selleslag D, Bird R, Newland A, Mayer J, Wang K, Olie R | 2020 | Am J Hematol | View Safety and efficacy of self-administered romiplostim in patients with immune thrombocytopenia: Results of an integrated database of five clinical trials | Researchers | Clinical research |
Safeguarding the Patient's Own Blood Supply | Zeller MP, Kaufman RM | 2019 | JAMA | View Safeguarding the Patient's Own Blood Supply | Health care providers | Clinical research |
Routine screening method for microparticles in platelet transfusions | Millar D, Murphy L, Labrie A, Maurer-Spurej E | 2018 | J Vis Exp | View Routine screening method for microparticles in platelet transfusions | Health care providers | New or improved product or process |
Routine nucleic acid testing of blood donations fails to detect all human immunodeficiency virus–positive blood donors | Fearon M, Scalia V, Lane D, Bigham M, Hawes G, O'Brien S, Kadkhoda K | 2016 | Transfusion | View Routine nucleic acid testing of blood donations fails to detect all human immunodeficiency virus–positive blood donors | Health care providers | Clinical research |
Routine clinical care data for population pharmacokinetic modeling: the case for Fanhdi/Alphanate in hemophilia A patients | Chelle P, Yeung CHT, Bonanad S, Morales Munoz JC, Ozelo MC, Megias Vericat JE, Iorio A, Spears J, Mir R, Edginton A | 2019 | J Pharmacokinet Pharmacodyn | View Routine clinical care data for population pharmacokinetic modeling: the case for Fanhdi/Alphanate in hemophilia A patients | Health care providers | Clinical research |
Role of von Willebrand factor and ADAMTS-13 in early brain injury after experimental subarachnoid hemorrhage | Wan H, Wang Y, Ai J, Brathwaite S, Ni H, Macdonald RL, Hol EM, Meijers JCM, Vergouwen MDI | 2018 | J Thromb Haemost | View Role of von Willebrand factor and ADAMTS-13 in early brain injury after experimental subarachnoid hemorrhage | Researchers | Basic research |
Role of G protein-coupled vasoactive intestinal peptide receptors in HIV integration | Branch DR | 2011 | Future Virol | View Role of G protein-coupled vasoactive intestinal peptide receptors in HIV integration | Researchers | Basic research |
Rivaroxaban and dabigatran did not affect clotting profiles in plasma reconstituted with varying levels of autologous platelets to the same degree as heparin when evaluated using thromboelastography | Gantioqui J, Stevic I, Atkinson H, Chan AKC | 2018 | Blood Coagul Fibrinolysis | View Rivaroxaban and dabigatran did not affect clotting profiles in plasma reconstituted with varying levels of autologous platelets to the same degree as heparin when evaluated using thromboelastography | Researchers | Basic research |
Rivaroxaban and Apixaban induce clotting factor Xa fibrinolytic activity | Carter RLR, Talbot K, Hur WS, Meixner SC, Van Der Gugten JG, Holmes DT, Côté HCF, Kastrup CJ, Smith TW, Lee AYY, Pryzdial ELG | 2018 | J Thromb Haemost | View Rivaroxaban and Apixaban induce clotting factor Xa fibrinolytic activity | Health care providers | Basic research |
Rituximab plus standard of care for treatment of primary immune thrombocytopenia: a systematic review and meta-analysis | Chugh S, Darvish-Kazem S, Lim W, Crowther MA, Ghanima W, Wang G, Heddle NM, Kelton JG, Arnold DM | 2015 | Lancet Haematol | View Rituximab plus standard of care for treatment of primary immune thrombocytopenia: a systematic review and meta-analysis | Health care providers | Clinical research |
Rituximab maintenance for relapsed refractory thrombotic thrombocytopenic purpura | Bhagirath VC, Kelton JG, Moore J, Arnold DM | 2012 | Transfusion | View Rituximab maintenance for relapsed refractory thrombotic thrombocytopenic purpura | Health care providers | Clinical research |
Risks, benefits and the role of stakeholders in pathogen reduction technology | Newbold KB, Heddle NM, Lane SJ, Arnold E, Eyles J, Webert K | 2014 | Health Risk Soc | View Risks, benefits and the role of stakeholders in pathogen reduction technology | Other | Other |
Risks and trends of red blood cell transfusion in obstetric patients: a retrospective study of 45,213 deliveries using administrative data | Shehata N, Chassé M, Colas JA, Murphy M, Forster AJ, Malinowski AK, Ducharme R, Fergusson DA, Tinmouth A, Wilson K | 2017 | Transfusion | View Risks and trends of red blood cell transfusion in obstetric patients: a retrospective study of 45,213 deliveries using administrative data | Health care providers | Clinical research |
Risk-based decision-making for blood safety: preliminary report of a consensus conference | Stein J, Besley J, Brook C, Hamill M, Klein E, Krewski D, Murphy G, Richardson M, Sirna J, Skinner M, Steiner R, van Aken P, Devine D | 2011 | Vox Sang | View Risk-based decision-making for blood safety: preliminary report of a consensus conference | Blood operators | Other |
Risk-based decision making in transfusion medicine | Leach Bennett J, Devine DV | 2018 | Vox Sang | View Risk-based decision making in transfusion medicine | Researchers | New or improved product or process |
Risk-assessment models for VTE and bleeding in hospitalized medical patients: an overview of systematic reviews | Darzi AJ, Repp AB, Spencer FA, Morsi RZ, Charide R, Etxeandia-Ikobaltzeta I, Bauer KA, Burnett AE, Cushman M, Dentali F, Kahn SR, Rezende SM, Zakai NA, Agarwal A, Karam SG, Lotfi T, Wiercioch W, Waziry R, Iorio A, Akl EA, Schünemann HJ | 2020 | Blood Adv | View Risk-assessment models for VTE and bleeding in hospitalized medical patients: an overview of systematic reviews | Health care providers | Clinical research |
Risk of transmission of severe acute respiratory syndrome coronavirus 2 by transfusion: A literature review | Leblanc J-F, Germain M, Delage G, O'Brien S, Drews SJ, Lewin A | 2020 | Transfusion | View Risk of transmission of severe acute respiratory syndrome coronavirus 2 by transfusion: A literature review | Health care providers | Clinical research |
Risk of transfusion-transmitted Babesia microti in Canada | O'Brien SF, Drews SJ, Yi Q-L, Bloch EM, Ogden NH, Koffi JK, Lindsay LR, Gregoire Y, Delage G | 2021 | Transfusion | View Risk of transfusion-transmitted Babesia microti in Canada | Researchers | Benchmarking and standard setting |
Risk of serious gastrointestinal bleeding in living kidney donors | Thomas SM, Lam NN, Huang A, Nash DM, Prasad GV, Knoll GA, Koval JJ, Lentine KL, Kim SJ, Alam A, Lok CE, Treleaven DJ, Garg AX | 2014 | Clin Transplant | View Risk of serious gastrointestinal bleeding in living kidney donors | Health care providers | Clinical research |
Risk of exposure to Zika virus and impact on cord blood banking and adult unrelated donors in hematopoietic cell transplantation: the Canadian Blood Services experience | Adams Z, Morris G, Campbell T, Mostert K, Dibdin N, Fearon M, Elmoazzen H, Mercer D, Young K, Allan D | 2018 | Biol Blood Marrow Transplant | View Risk of exposure to Zika virus and impact on cord blood banking and adult unrelated donors in hematopoietic cell transplantation: the Canadian Blood Services experience | Blood operators | Clinical research |
Risk of exposure to blood products during pregnancy: guidance for Zika and other donor deferral policies | Murphy MS, Shehata N, Colas JA, Chassé M, Fergusson DA, O'Brien SF, Goldman M, Tinmouth A, Forster AJ, Wilson K | 2017 | Transfusion | View Risk of exposure to blood products during pregnancy: guidance for Zika and other donor deferral policies | Health care providers | Clinical research |
Risk of acute kidney injury in patients randomized to a restrictive versus liberal approach to red blood cell transfusion in cardiac surgery: a substudy protocol of the transfusion requirements in cardiac surgery III noninferiority trial | Garg AX, Shehata N, McGuinness S, Whitlock R, Fergusson D, Wald R, Parikh C, Bagshaw SM, Khanykin B, Gregory A, Syed S, Hare GMT, Cuerden MS, Thorpe KE, Hall J, Verma S, Roshanov PS, Sontrop JM, Mazer CD | 2018 | Can J Kidney Health Dis | View Risk of acute kidney injury in patients randomized to a restrictive versus liberal approach to red blood cell transfusion in cardiac surgery: a substudy protocol of the transfusion requirements in cardiac surgery III noninferiority trial | Researchers | Clinical research |
Risk infection to spare bleeding? The quandary of splenectomy for immune thrombocytopenia | Zeller M, Arnold DM | 2015 | Am J Hematol | View Risk infection to spare bleeding? The quandary of splenectomy for immune thrombocytopenia | Health care providers | Clinical research |
Risk factors for neonatal thrombosis: A retrospective study conducted in a single Canadian intensive care unit | Bhatia K, Solanki S, Paes B, Chan AKC, Bhatt MD | 2022 | Pediatr Blood Cancer | View Risk factors for neonatal thrombosis: A retrospective study conducted in a single Canadian intensive care unit | Researchers | Clinical research |
Risk factors for bleeding in people living with hemophilia A and B treated with regular prophylaxis: A systematic review of the literature | Germini F, Noronha N, Abraham Philip B, Olasupo O, Pete D, Navarro T, Keepanasseril A, Matino D, de Wit K, Parpia S, Iorio A | 2022 | J Thromb Haemost | View Risk factors for bleeding in people living with hemophilia A and B treated with regular prophylaxis: A systematic review of the literature | Researchers | Clinical research |
Risk factors and impact of major bleeding in critically ill patients receiving heparin thromboprophylaxis | Lauzier F, Arnold DM, Rabbat C, Heels-Ansdell D, Zarychanski R, Dodek P, Ashley BJ, Albert M, Khwaja K, Ostermann M, Skrobik Y, Fowler R, McIntyre L, Nates JL, Karachi T, Lopes RD, Zytaruk N, Finfer S, Crowther M, Cook D | 2013 | Intensive Care Med | View Risk factors and impact of major bleeding in critically ill patients receiving heparin thromboprophylaxis | Health care providers | Clinical research |
Risk analysis of transfusion of cryoprecipitate without consideration of ABO group | Hadjesfandiari N, Levin E, Serrano K, Yi Q-L, Devine DV | 2021 | Transfusion | View Risk analysis of transfusion of cryoprecipitate without consideration of ABO group | Health care providers | Benchmarking and standard setting |
Rights and interests in human bodies and biological materials | Toews M, Caulfield T, Nelson E, Ogbogu U, Hartell D | 2015 | Canadian National Transplant Research Program Fast Policy Facts: Human Bodies and Biological Materials | View Rights and interests in human bodies and biological materials | Other | Other |
rIgG1 Fc hexamer inhibits antibody-mediated autoimmune disease via effects on complement and FcgammaRs | Spirig R, Campbell IK, Koernig S, Chen CG, Lewis BJB, Butcher R, Muir I, Taylor S, Chia J, Leong D, Simmonds J, Scotney P, Schmidt P, Fabri L, Hofmann A, Jordi M, Spycher MO, Cattepoel S, Brasseit J, Panousis C, Rowe T, Branch DR, Baz Morelli A, Kasermann F, Zuercher AW | 2018 | J Immunol | View rIgG1 Fc hexamer inhibits antibody-mediated autoimmune disease via effects on complement and FcgammaRs | Researchers | Basic research |
rIgG1 Fc Hexamer Inhibits Antibody-Mediated Autoimmune Disease via Effects on Complement and Fc?Rs | Spirig R, Campbell IK, Koernig S, Chen C-G, Lewis BJB, Butcher R, Muir I, Taylor S, Chia J, Leong D, Simmonds J, Scotney P, Schmidt P, Fabri L, Hofmann A, Jordi M, Spycher MO, Cattepoel S, Brasseit J, Panousis C, Rowe T, Branch DR, Baz Morelli A, Kaesermann F, Zuercher AW | 2018 | J Immunol | View rIgG1 Fc Hexamer Inhibits Antibody-Mediated Autoimmune Disease via Effects on Complement and Fc?Rs | Researchers | Basic research |
Riboflavin and ultraviolet light treatment potentiates vasodilator-stimulated phosphoprotein Ser-239 phosphorylation in platelet concentrates during storage | Schubert P, Culibrk B, Coupland D, Scammell K, Gyongyossy-Issa M, Devine DV | 2012 | Transfusion | View Riboflavin and ultraviolet light treatment potentiates vasodilator-stimulated phosphoprotein Ser-239 phosphorylation in platelet concentrates during storage | Researchers | Basic research |
Riboflavin and ultraviolet light treatment of platelets triggers p38MAPK signaling: inhibition significantly improves in vitro platelet quality after pathogen reduction treatment | Schubert P, Coupland D, Culibrk B, Goodrich RP, Devine DV | 2013 | Transfusion | View Riboflavin and ultraviolet light treatment of platelets triggers p38MAPK signaling: inhibition significantly improves in vitro platelet quality after pathogen reduction treatment | Researchers | Basic research |
Riboflavin and ultraviolet illumination affects selected platelet mRNA transcript amounts differently | Klein-Bosgoed C, Schubert P, Devine DV | 2016 | Transfusion | View Riboflavin and ultraviolet illumination affects selected platelet mRNA transcript amounts differently | Researchers | Basic research |
RhoA/ROCK signaling contributes to sex differences in the activation of human platelets | Schubert P, Coupland D, Nombalais M, Walsh G, Devine DV | 2016 | Thromb Res | View RhoA/ROCK signaling contributes to sex differences in the activation of human platelets | Researchers | Basic research |
RhD Specific Antibodies Are Not Detectable in HLA-DRB1(*)1501 Mice Challenged with Human RhD Positive Erythrocytes | Bernardo L, Denomme GA, Shah K, Lazarus AH | 2014 | Adv Hematol | View RhD Specific Antibodies Are Not Detectable in HLA-DRB1(*)1501 Mice Challenged with Human RhD Positive Erythrocytes | Researchers | Basic research |
Rh System: Anti-V | Meunier D, Peng S, Clarke G | 2019 | Blood.ca website | View Rh System: Anti-V | Health care providers | Benchmarking and standard setting |
Rh System: Anti-Cw | Meunier D, Peng S, Clarke G | 2019 | Blood.ca website | View Rh System: Anti-Cw | Health care providers | Benchmarking and standard setting |
Revisiting study design and methodology for pathogen reduced platelet transfusions: a round table discussion | Heddle NM, Cardoso M, van der Meer PF | 2020 | Transfusion | View Revisiting study design and methodology for pathogen reduced platelet transfusions: a round table discussion | Researchers | Clinical research |
Reversible hemostatic properties of sulfabetaine/quaternary ammonium modified hyperbranched polyglycerol | Wen J, Weinhart M, Lai B, Kizhakkedathu J, Brooks DE | 2016 | Biomaterials | View Reversible hemostatic properties of sulfabetaine/quaternary ammonium modified hyperbranched polyglycerol | Researchers | Basic research |
Revealing the diversity of extracellular vesicles using high-dimensional flow cytometry analyses | Marcoux G, Duchez A-C, Cloutier N, Provost P, Nigrovic PA, Boilard E | 2016 | Sci Rep | View Revealing the diversity of extracellular vesicles using high-dimensional flow cytometry analyses | Researchers | Basic research |
Rethinking platelet transfusion practices | Devine DV | 2021 | Blood | View Rethinking platelet transfusion practices | Health care providers | New or improved product or process |